{"disease":{"id":"anal-intraepithelial-neoplasia","name":"anal intraepithelial neoplasia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06866574","title":"A Phase III Trial to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.Coli) in Chinese Males","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":9300,"lead_sponsor_name":"Xiamen University","has_results":false},{"nct_id":"NCT03713229","title":"Seville Cohort of People Living With HIV at Risk for Anal Cancer","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":3000,"lead_sponsor_name":"Hospitales Universitarios Virgen del Rocío","has_results":false},{"nct_id":"NCT01651949","title":"Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2520,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT05074264","title":"Screening Algorithms for Cervical and Anal High-Grade Squamous Intraepithelial Lesions in People With HIV in Mexico and Puerto Rico","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1586,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT03947775","title":"HPV-SAVE_Merck_Sub-Study for Preventing Recurrence of HSIL","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":228,"lead_sponsor_name":"University Health Network, Toronto","has_results":false},{"nct_id":"NCT05835947","title":"Anal Cancer Risk In Women","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Imperial College London","has_results":false},{"nct_id":"NCT06327568","title":"Anal Cancer and/or Precancer Screening: Performance Analysis of the BD Onclarity™ HPV Assay on Anal Specimens","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"European Institute of Oncology","has_results":false},{"nct_id":"NCT03051516","title":"HPV Vaccine Therapy in Interrupting Progression in Patients With High-Grade Vulvar or Anal Lesions","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":188,"lead_sponsor_name":"Fred Hutchinson Cancer Center","has_results":true},{"nct_id":"NCT04055142","title":"Clinical Trial for Evaluating the Efficacy and Safety of Electrocoagulation vs Topic Sinecatechins vs Topic Cidofovir Within the Treatment to High-grade Anal Intraepithelial Neoplasia in HIV Homosexual Males","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":108,"lead_sponsor_name":"Hospital Universitari Vall d'Hebron Research Institute","has_results":false},{"nct_id":"NCT02059499","title":"Imiquimod, Fluorouracil, or Observation in Treating HIV-Positive Patients With High-Grade Anal Squamous Skin Lesions","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":91,"lead_sponsor_name":"AIDS Malignancy Consortium","has_results":true},{"nct_id":"NCT03603808","title":"VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal Lesions","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"AIDS Malignancy Consortium","has_results":false},{"nct_id":"NCT05858021","title":"COrSIcA: Disease Measurement","phase":"","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"David Finch","has_results":false},{"nct_id":"NCT05835960","title":"Anal Intraepithelial Neoplasia and Anal Squamous Cell Carcinoma","phase":"","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Imperial College London","has_results":false},{"nct_id":"NCT04276935","title":"Development of a Health-Related Symptom Index for Participants With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions","phase":"","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"AIDS Malignancy Consortium","has_results":true},{"nct_id":"NCT03100045","title":"Intra-Anally Administered Artesunate in Patients With High-Grade Anal Intraepithelial Neoplasia (AIN 2/3)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Johns Hopkins University","has_results":false}],"total":15},"guidelines":[],"source":"Drug Landscape verified database"}